These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 25906652)

  • 1. [State of intestinal microbiota in patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease].
    Lytvynenko KO; Bodnar PM; Lysiana TO; Ponomar'ova IH; Koval'chuk OA
    Lik Sprava; 2014; (5-6):82-7. PubMed ID: 25906652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic review: microbial dysbiosis and nonalcoholic fatty liver disease.
    Wieland A; Frank DN; Harnke B; Bambha K
    Aliment Pharmacol Ther; 2015 Nov; 42(9):1051-63. PubMed ID: 26304302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity, fatty liver disease and intestinal microbiota.
    Arslan N
    World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An altered fecal microbiota profile in patients with non-alcoholic fatty liver disease (NAFLD) associated with obesity.
    Nistal E; Sáenz de Miera LE; Ballesteros Pomar M; Sánchez-Campos S; García-Mediavilla MV; Álvarez-Cuenllas B; Linares P; Olcoz JL; Arias-Loste MT; García-Lobo JM; Crespo J; González-Gallego J; Jorquera Plaza F
    Rev Esp Enferm Dig; 2019 Apr; 111(4):275-282. PubMed ID: 30810328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study.
    Motta BM; Grander C; Gögele M; Foco L; Vukovic V; Melotti R; Fuchsberger C; De Grandi A; Cantaloni C; Picard A; Mascalzoni D; Rossini A; Pattaro C; Tilg H; Pramstaller PP
    J Transl Med; 2019 Dec; 17(1):408. PubMed ID: 31801616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis.
    Li F; Ye J; Shao C; Zhong B
    Lipids Health Dis; 2021 Feb; 20(1):22. PubMed ID: 33637088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease is associated with dysbiosis independent of body mass index and insulin resistance.
    Da Silva HE; Teterina A; Comelli EM; Taibi A; Arendt BM; Fischer SE; Lou W; Allard JP
    Sci Rep; 2018 Jan; 8(1):1466. PubMed ID: 29362454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.
    Panasevich MR; Peppler WT; Oerther DB; Wright DC; Rector RS
    Physiol Genomics; 2017 Aug; 49(8):385-399. PubMed ID: 28600319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gut microbiota and nonalcoholic steatohepatitis].
    Kessoku T; Imajo K; Kobayashi T; Honda Y; Ogawa Y; Yoneda M; Saito S; Nakajima A
    Nihon Yakurigaku Zasshi; 2018; 152(4):187-193. PubMed ID: 30298840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disorders of gut microflora in the pathogenesis of liver cirrhosis and complications of portal hypertension].
    Anikina EV; Kovtun AV; Iakovenko AV; Gioeva IZ; Iakovenko ÉP; Agafonova NA; Ivanov AN; Volosheĭnikova TV; Grigor'eva IuV
    Eksp Klin Gastroenterol; 2014; (12):20-3. PubMed ID: 26058107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut Microbiota and Complications of Liver Disease.
    Acharya C; Bajaj JS
    Gastroenterol Clin North Am; 2017 Mar; 46(1):155-169. PubMed ID: 28164848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
    Han JL; Lin HL
    World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease.
    Wang B; Jiang X; Cao M; Ge J; Bao Q; Tang L; Chen Y; Li L
    Sci Rep; 2016 Aug; 6():32002. PubMed ID: 27550547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders.
    Aron-Wisnewsky J; Vigliotti C; Witjes J; Le P; Holleboom AG; Verheij J; Nieuwdorp M; Clément K
    Nat Rev Gastroenterol Hepatol; 2020 May; 17(5):279-297. PubMed ID: 32152478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut dysbiosis and detection of "live gut bacteria" in blood of Japanese patients with type 2 diabetes.
    Sato J; Kanazawa A; Ikeda F; Yoshihara T; Goto H; Abe H; Komiya K; Kawaguchi M; Shimizu T; Ogihara T; Tamura Y; Sakurai Y; Yamamoto R; Mita T; Fujitani Y; Fukuda H; Nomoto K; Takahashi T; Asahara T; Hirose T; Nagata S; Yamashiro Y; Watada H
    Diabetes Care; 2014 Aug; 37(8):2343-50. PubMed ID: 24824547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?
    Betrapally NS; Gillevet PM; Bajaj JS
    Gastroenterology; 2016 Jun; 150(8):1745-1755.e3. PubMed ID: 26948887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Fungi Dysbiosis in Nonalcoholic Fatty Liver Disease.
    You N; Xu J; Wang L; Zhuo L; Zhou J; Song Y; Ali A; Luo Y; Yang J; Yang W; Zheng M; Xu J; Shao L; Shi J
    Obesity (Silver Spring); 2021 Feb; 29(2):350-358. PubMed ID: 33491316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.